Folstein S E, Jensen B, Leigh R J, Folstein M F
Neurobehav Toxicol Teratol. 1983 Nov-Dec;5(6):605-9.
Clinical and laboratory methods were developed to detect motor abnormalities in patients with Huntington Disease. For clinical evaluation a quantitated neurological examination was used which factor analyzed into 2 scales: a chorea scale (a measure of involuntary movement) and a motor impairment scale (a measure of abnormalities of voluntary movement). Mechanized methods of measuring involuntary movement (accelerometer) and voluntary movement (reaction time, tapping speed, and movement time) were also developed. The motor abnormalities detected on the clinical and mechanical tests were not specific to HD but were also present in persons at 50% risk for HD and in patients with a variety of neurological disorders. The mechanized tests may be useful for screening for motor disorders in the population: they are non-specific, portable and do not require the services of an experienced clinician.
已经开发出临床和实验室方法来检测亨廷顿舞蹈症患者的运动异常。对于临床评估,采用了定量神经学检查,该检查被分解为两个量表:舞蹈症量表(衡量不自主运动)和运动障碍量表(衡量自主运动异常)。还开发了测量不自主运动(加速度计)和自主运动(反应时间、敲击速度和运动时间)的机械化方法。在临床和机械测试中检测到的运动异常并非HD所特有,在患HD风险为50%的人群以及患有各种神经疾病的患者中也存在。机械化测试可能有助于在人群中筛查运动障碍:它们是非特异性的、便于携带的,并且不需要经验丰富的临床医生服务。